Oral glucosamine sulphate in the management of arthrosis: report on a multi-centre open investigation in Portugal.

Pharmatherapeutica 02/1982; 3(3):157-68.
Source: PubMed

ABSTRACT An open study was carried out by 252 doctors throughout Portugal to assess the effectiveness and tolerability of oral glucosamine sulphate in the treatment of arthrosis. Patients received 1.5 g daily in 3 divided doses over a mean period of 50 +/- 14 days. The results from 1208 patients were analyzed and showed that the symptoms of pain at rest, on standing and on exercise and limited active and passive movements improved steadily through the treatment period. The improvement obtained lasted for a period of 6 to 12 weeks after the end of treatment. Objective therapeutic efficacy was rated by the doctors as 'good' in 59% of patients, and 'sufficient' in a further 36%. These results were significantly better than those obtained with previous treatments (except for injectable glucosamine) in the same patients. Sex, age, localization of arthrosis, concomitant illnesses or concomitant treatments did not influence the frequency of responders to treatment. Oral glucosamine was fully tolerated by 86% of patients, a significantly larger proportion than that reported with other previous treatments and approached only by injectable glucosamine. The onset of possible side-effects was significantly related to pre-existing gastro-intestinal disorders and related treatments, and to concomitant diuretic treatment.

  • Source
    Inflammation and Regeneration 01/2006; 26(5):446-452. DOI:10.2492/inflammregen.26.446
  • [Show abstract] [Hide abstract]
    ABSTRACT: This study was performed to evaluate tissue reactions induced in rats by polyester non-woven fabric (NWF, 1×1cm2, 0.6mm thick) impregnated with chitin or chitosan suspension ranging from 0.1 to 50mg/ml (chitin-NWF, chitosan-NWF) and NWF impregnated with phosphated buffer solution (control). Evaluations were based on macroscopic and microscopic observations, and image analysis of histological samples stained with Alcian blue, Safranin O, and Masson trichrome for identifying glycosaminoglycan, proteoglycan, and collagen, respectively. Macroscopically, the NWFs impregnated with higher concentrations of chitin (50mg/ml) and chitosan (10mg/ml) suspensions evoked more strong reactions than those impregnated with weaker concentrations of chitin (1.0 and 10mg/ml) and chitosan (0.1 and 1.0mg/ml) suspensions and were characterized by thickening of the NWF at Day 7 of the implantation. There was swelling and accumulation of exudates in the NWF impregnated with 50 and 10mg/ml of chitin and chitosan suspensions, respectively. However, in microscopic examination, organization of the NWF implants was found to be superior in the NWF impregnated with weaker suspensions of chitin and chitosan. The chitin groups at higher concentrations showed higher value than the controls in the sections prepared with Alcian blue staining, but lower values in the sections prepared by Safranin O staining. In the Masson's trichrome staining, the chitin groups at lower concentrations showed lower values than the control. The chitosan groups were similar to the control in all special stainings.
    Carbohydrate Polymers 11/2001; 46(3):235-239. DOI:10.1016/S0144-8617(00)00326-X · 3.92 Impact Factor
  • Physical Therapy in Sport 11/2004; 5(4):169-171. DOI:10.1016/j.ptsp.2004.09.001 · 1.37 Impact Factor


Available from
Jun 6, 2014